Audible CFS book

CFS book You Tube

Thursday, July 09, 2015

An Important Message for European, Russian and Asian Intellectuals and Scientists:

HIVism is the Nazism of our time. All people of conscience must speak out against it.


Virtually all of the nosology, epidemiology and virology about AIDS, Chronic Fatigue Syndrome, HIV and HHV-6/7/8 that has come out of America's CDC and France's Pasteur Institute is totally fraudulent. Believe any of it at your own risk. 

It may be up to you to perform the most important scientific course correction in history.

Keep up with the latest developments on this massive scientific fraud at The Hannah Arendt University System.

The dark side of Rituximab

Severe and sometimes fatal infusion reactions may occur with rituximab. These reactions may occur while you receive rituximab or within 24 hours after you receive it. Tell your doctor right away if you develop blurred vision, chest pain, cough, dizziness, drowsiness, fainting, fast or irregular heartbeat, headache, hives, itching, numbness of an arm or leg, shortness of breath, swelling (eg, lips, tongue, throat, face), trouble breathing, weakness, or wheezing while you receive or after you receive rituximab.
Severe and sometimes fatal skin and mouth reactions (Stevens-Johnson syndrome/toxic epidermal necrolysis) may occur during treatment with rituximab. Tell your doctor right away if you experience red, swollen, peeling, or blistered skin; or sores or ulcers on your skin, lips, or in your mouth.
If you have had hepatitis B before or carry the virus, rituximab can cause the virus to become active again. This can lead to severe and sometimes deadly liver problems. Your doctor will watch you for hepatitis B infection before treatment, while you take rituximab, and for several months after you stop rituximab. Do not take rituximab if you have active hepatitis liver disease.
A rare viral infection of the brain (progressive multifocal leukoencephalopathy [PML]) can occur with the use of rituximab in certain patients. PML is serious and sometimes fatal. Most cases of PML have occurred within 12 months of the last dose of rituximab. Tell your doctor right away if you notice new or worsening medical problems, such as confusion, disorientation, or problems thinking; decreased strength or weakness; unusual vision problems (eg, blurred vision, loss of vision); trouble walking or talking; or loss of balance or coordination.

 http://www.drugs.com/cdi/rituximab.html

The CDC's big problem:


Is Rituximab really controlling HHV-8 in CFS patients?



http://asheducationbook.hematologylibrary.org/content/2013/1/103.full



Prevalence in the cerebrospinal fluid of the following infectious agents in a cohort of 12 CFS subjects: human herpes virus-6 and 8; chlamydia species; mycoplasma species; EBV; CMV; and Coxsackievirus.

Levine, S. Journal of Chronic Fatigue Syndrome, 2001, 9, 1/2, 41-51.

Abstract: Over the last decade a wide variety of infectious agents have been associated with the CFS as potential etiologies for this disorder. Many of these agents are neurotrophic and have been linked previously to other diseases involving the central nervous system (CNS). Human herpes virus-6 (HHV-6), especially the B variant, has been found in autopsy specimens of patients who suffered from MS. Because patients with CFS manifest a wide range of symptoms involving the CNS as shown by abnormalities on brain MRIs, SPECT scans of the brain and results of tilt table testing we sought to determine the prevalence of HHV-6, HHV-8, Epstein-Barr Virus (EBV), cytomegalovirus (CMV), mycoplasma species, chlamydia species, and Coxsackie virus in the spinal fluid of a group of 12 patients with CFS (CDC criteria '94).
We found evidence of HHV-6, HHV-8, chlamydia species, CMV and Coxsackie virus in 6/12 samples. Plasma tests were negative. It was surprising to obtain such a relatively high yield of infectious agents in cell free specimens of spinal fluid that had not been centrifuged. Future research in spinal fluid analysis, in addition to testing tissue samples by polymerase chain reaction (PCR) and other direct viral isolation techniques will be important in characterizing subpopulations of CFS patients, especially those with involvement of the CNS.
The low rate of isolation of HHV-6 may be related to the lack of gross neurological findings in the patients at the time of testing.


Crimson Crescents Facilitate CFS Diagnosis
By Robert B. Marchesani
Infectious Disease News, November 1992
MINEOLA, NY—A new physical finding in chronic fatigue syndrome patients may finally give clinicians what they have only dreamed about a clinical way to diagnose the disease.
Burke A. Cunha, MD, discovered what he called crimson crescents in the mouths of 80% of his CFS patients. 

If Most CFS patients have crimson crescents, then most probably have HHV-8/K.S. in some form.

CFS Patients' "Crimson Crescents" May Be Diagnostic Of The Syndrome
A Long Island physician who studies CFS, Dr. Burke A. Cunha, has discovered what he calls "crimson crescents" in the throats of CFS patients. The crescents are so distinctive that Dr. Cunha believes that their presence indicates that CFS is present, even if the physician (or the patient) observes no other indication of the syndrome. Even more intriguing, Dr. Cunha has found that the crescents are associated with high levels of Human Herpes Virus 6 (HHV-6), a virus that is found to be actively growing in AIDS and CFS patients.
Dr. Cunha described his finding in a medical journal, and in November 1992, it was the cover story of the Infectious Disease News, a newsletter for primary care physicians. The crescents are described as being "crimson purple," and looking like half of a crescent moon.
Dr. Cunha says the crescents occur in 80 percent of CFS patients.
After he reported his finding in the Annals of Internal Medicine, Dr. Cunha says he received calls from physicians all over the country. They told Dr. Cunha that, once they knew to look for the crescents, they were also finding them in their CFS patients.
Dr. Cunha thinks that many physicians may not have seen the crescents because they occur on both sides of the back of the throat, behind the back molars. Most physicians, Dr. Cunha remarked to Infectious Disease News, don't really look at the sides of the throat.
Dr. Cunha is convinced that the crimson crescents are highly correlated with CFS. "If your patient has crimson crescents, you can now say it is probably chronic fatigue syndrome," Dr. Cunha told Infectious Disease News.
Dr. Cunha also said, however, that he has found the crimson crescents in three to five percent of all patients who complain of sore throat -- which may mean that the number of peoople who have CFS has been grossly underestimated. The crescents have not been seen in patients with other illnesses that produce sore throats, such as mononucleosois, strep throat, cytomegalovirus infection of the throat, or common viral sore throat.
Dr. Cunha thinks that the crescents may occur in CFS patients because they are caused by the active HHV-6 found in the patients.
"I believe that the virus that causes chronic fatigue comes from young adults or children who give it to adults," Dr. Cunha told Infectious Disease News. "...I don't know why there is a difference, but the children do not have chronic fatigue. HHV-6 is a virus of children, and it may manifest as chronic fatigue in adults."
Dr. Cunha is trying to culture HHV-6 out of the crescents, but he has found that laboratories that perform throat cultures usually do not have the facilities to detect HHV-6, which is a fairly new human virus. To try to find HHV-6, he plans to perform biopsies on the crescents, Dr. Cunha told Infectious Disease News.
Dr. Cunha also pointed out that increased HHV-6 and decreased natural killer cell activity are the two most consistent laboratory findings in CFS. He thinks that the presence of the crimson crescents by themselves, however, are evidence enough that CFS is present.
"If you are a physician out in the middle of nowhere and you can't get HHV-6 titers and you can't get the natural killer cell percentage, then the crimson crescents may be the only way besides history that can suggest the diagnosis" of CFS, Dr. Cunha told Infectious Disease News.


Back to basics!


What the CFS community, the gay community and the black community should be saying to the Centers for Disease Control:

Why Chronic Fatigue Syndrome should be a reportable disease.

HHV-6 as a cancer-causing virus: Identification of human herpesvirus 6 uracil-DNA glycosylase gene

 Uracil-DNA glycosylase encoded in many species functions as a DNA repair enzyme that removes uracil residues from DNA. To investigate the potential function of uracil-DNA glycosylase encoded by human herpes-virus 6 (HHV-6), we sequenced a DNA clone (pSTY09), identified an open reading frame of 765 bp and compared the putative amino acid sequence with other uracil-DNA glycosylases, by computer analysis. The amino acid sequence of HHV-6 had similarities to other uracil-DNA glycosylases, with the highest degree of similarity to those of human cytomegalovirus and Epstein-Barr virus. Two strongly conserved regions in uracil-DNA glycosylase of other species also existed in HHV-6. The gene product which was expressed in demonstrated uracil-DNA glycosylase activity. This is the first report to identify and characterize the uracil-DNA glycosylase gene in HHV-6.

http://jgv.sgmjournals.org/content/journal/jgv/10.1099/0022-1317-75-9-2349

Background on the uracil-DNA glycosylase gene
 This gene encodes one of several uracil-DNA glycosylases. One important function of uracil-DNA glycosylases is to prevent mutagenesis by eliminating uracil from DNA molecules by cleaving the N-glycosylic bond and initiating the base-excision repair (BER) pathway. Uracil bases occur from cytosine deamination or misincorporation of dUMP residues. Alternative promoter usage and splicing of this gene leads to two different isoforms: the mitochondrial UNG1 and the nuclear UNG2. The UNG2 term was used as a previous symbol for the CCNO gene (GeneID 10309), which has been confused with this gene, in the literature and some databases.
http://www.ncbi.nlm.nih.gov/gene/7374


The HHV-6 Rights of Man

1. The right not to be lied to about the role of HHV-6 in AIDS.

2. The right not to be lied to about the role of HHV-6 in Chronic Fatigue Syndrome.

3. The right not to be lied to about the role of HHV-6 in Autism.

4.The right not to be lied to about the role of HHV-6 in Multiple Sclerosis.

5. The right not to be lied to about the role of HHV-6 in Brain Cancer.

6. The right not to be lied to about the role of HHV-6 in Heart Disease.

7. The right not to be lied to about the role of HHV-6 in Encephalitis.

8. The right not to be lied to about the role of HHV-6 in Cognitive Dysfunction.

9. The right not to be lied to about the role of HHV-6 in Drug Hypersensitivity Syndrome.

10. The right not to be lied to about the role of HHV-6 in Bone Marrow Suppression.

11. The right not to be lied to about the role of HHV-6 in Lymphadenopathy.

 12. The right not to be lied to about the role of HHV-6 in Colitis.

13. The right not to be lied to about the role of HHV-6 in Endocrine Disorders.

14. The right not to be lied to about the role of HHV-6 in Liver Disease.

 15. The right not to be lied to about the role of HHV-6 in Hodgkin's Lymphoma.

 16. The right not to be lied to about the role of HHV-6 in Glioma.

17. The right not to be lied to about the role of HHV-6 in Cervical Cancer.

18. The right not to be lied to about the role of HHV-6 in Hypogammaglobulinemia.

 19. The right not to be lied to about the role of HHV-6 in Optic Neuritis.

20. The right not to be lied to about the role of HHV-6 in Microangiopathy.

21. The right not to be lied to about the role of HHV-6 in Mononucleosis.

22. The right not to be lied to about the role of HHV-6 in Uveitis.

23. The right not to be lied to about the role of HHV-6 in Stevens-Johnson Syndrome.

24. The right not to be lied to about the role of HHV-6 in Rhomboencephalitis.

25. The right not to be lied to about the role of HHV-6 in Limbic Encephalitis.

26. The right not to be lied to about the role of HHV-6 in Encephalomyelitis

27. The right not to be lied to about the role of HHV-6 in Pneumonitis.

28. The right not to be lied to about the role of HHV-6 in GVHD.

29. The right not to be lied to about the role of HHV-6 in Ideopathic Pneumonia.

30. The right not to be lied to about the role of HHV-6 in Pediatric Adrenocortical Tumors

31. The right not to be lied to about the role of HHV-6 in the reactivation of endogenous retroviruses.

32. The right not to be lied to about the impact of HHV-6 on T-Cells.

33. The right not to be lied to about the impact of HHV-6 on B-Cells

34. The right not to be lied to about the impact of HHV-6 on Epithelial Cells.

35. The right not to be lied to about the the impact of HHV-6 on Natural Killer Cells.

35. The right not to be lied to about the the impact of HHV-6 on Dendritic Cells.

36. The right not to be lied to about the the impact of HHV-6 infection of the brain.

 37. The right not to be lied to about the the impact of HHV-6 infection of the liver.

38. The right not to lied to about the ability of HHV-6 to affect cytokine production.

39. The right not to be lied to about the ability of HHV-6 to affect Aortic and Heart Microvascular Endothelial cells.

40. The right not to be lied to about the role of an HHV-6 cover-up in a massive HIV Fraud Ponzi Scheme that in a number of ways resembles the Tuskegee Syphilis Experiment and Nazi medicine.


If HHV-6 is the real cause of AIDS, here are some of the implications:

1. HIV is a massive scientific fraud. Something akin to a Ponzi scheme. Scientists who challenged the HIV theory of AIDS (the ones who have been thuggishly censored and silenced) turn out to be on the money.

2. Chronic Fatigue Syndrome and Autism (and many other so-called HHV-6 related mysterious epidemics) are part of the so-called AIDS epidemic.  Chronic Fatigue Syndrome and Autism both are clearly the results of the ravages of HHV-6.

3. AIDS and Chronic Fatigue Syndrome has been artificially and politically separated into two epidemics. We are living in a period of CFS/AIDS apartheid. So-called AIDS patients have to sit in the back of the HHV-6 epidemic bus while the befuddled HHV-6/CFS patients and HHV-6/Autism victims sit up front. Nobody is well-served.

4. AIDS is not a sexually transmitted disease. That paradigm has set a scapegoating and antigay agenda in place that the public thinks is solidly based on science. It is only based on homophobic and racist nosology, epidemiology and virology. The scientists behind the paradigm are charlatans and crooks.

5. The Centers for Disease Control in Atlanta and the Pasteur Institute in Paris have a great deal in common with the institutions of Nazi medicine. For Blacks, everything these institutions have done in the name of AIDS really constitutes a second Tuskegee Syphilis Experiment.

Elements of a Scientific Ponzi Scheme like the Montagnier-Agut HIV Fraud Ponzi Scheme and HHV-6 Cover-up

A scientific Ponzi scheme begins with a central seminal or foundational scientific fraud and is  sometimes built on an infrastructure of smaller scientific frauds. Like the fake dividends issued in a strictly financial Ponzi scheme, a scientific Ponzi scheme issues fake dividends in the form of ongoing fraud-based research often framed as "breakthroughs" and bogus extrapolations which make it look like everything is above board and that what, in reality, is scientific fraud, appears to the rest of the scientific community and the public as good faith progress.

A classic scientific Ponzi scheme like the Montgnier-Agut HIV Fraud Ponzi Scheme and HHV-6 Cover-up include elements like these:

1. Nosological fraud.

2. Epidemiological fraud.

3. Virological fraud.

4. Treatment fraud.

5. Public health policy fraud.

6. Concealment of negative scientific data and paradigm-challenging anomalies.

7.  Use of an elite network of "old boys" and pseudo-activist provocateurs to censor critics and whistleblowers.

8. Chronic obscurantism.

9. If necessary, vigilantism and witch-hunts against any intellectuals, scientists, or citizens who constitute any form of resistance to the Ponzi scheme.

10. A subservient scientific press that is used as a conveyor belt for the Ponzi scheme's propaganda.

Everything always looks like it is working perfectly in a Ponzi scheme, until the moment comes when someone look at the books and blows the whistle.  Hopefully, that game-changing moment for the Montagnier-Agut HIV Fraud Ponzi Scheme and HHV-6 Cover-up is coming soon.

Will the Rituximab Revolution help end the CDC cover-up of America's biggest epidemic?

The Rituximab Revoltuion may be a nightmare for the Centers for Disease Control as it makes the public aware of the following issues:

The Rituximab Revolution may make millions of people aware that they need serious chemotherapy with all kinds of possible side effect for a disease he CDC has covered up for three decades.

The Rituximab Revolution may make millions of people aware that Chronic Fatigue Syndrome really is a form of AIDS. (Judy Mikovits has called it "HIV-negative AIDS.)

The Rituximab Revolution could make the public also relize that everything the CDC has told the public about AIDS is fraud and bullshit.

The Rituximab Revolution may make it clear that we are in the middle of a HHV-6/7/8 epidemic.

Keep up with the Rituximab Revolution at 

Previous posts

An excerpt from THE CHRONIC FATIGUE SYNDROME EPIDEMIC COVER-UP

CFS Book top ad

Kindle free trial

Individual chapters

Want to check out individual chapters of our best seller? Click books below for previews of each individual chapter of THE CHRONIC FATIGUE SYNDROME EPIDEMIC COVER-UP available for only $2.99 on KINDLE or free on KINDLE Unlimited.

Popular Posts in the Last 30 Days

Blog Archive

Closing Argument Audible

African Swine Fever Novel Audible

Stonewall Audible